Example: Heart Attack

Search clinical trials for: Dalcetrapib

Total 17 results

NCT04676867

Recruiting

Effect of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19

Conditions: Covid19
NCT02525939

Active, not recruiting

Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS

Conditions: Acute Coronary Syndrome
NCT01323153

Completed

A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)

Conditions: Coronary Heart Disease
NCT01059682

Terminated

A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease

Conditions: Cardiovascular Disease
NCT01516541

Completed

A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease

Conditions: Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)
NCT01476267

Completed

A Study of the Metabolic Profile of Dalcetrapib in Healthy Volunteers

Conditions: Healthy Volunteer
NCT01363999

Completed

A Formulation Screening Study of Dalcetrapib and Atorvastatin in Healthy Volunteers

Conditions: Healthy Volunteer
NCT00353522

Completed

A Study of RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent.

Conditions: Coronary Heart Disease
NCT00688558

Completed

Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels

Conditions: Dyslipidemia
NCT00689442

Completed

Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels

Conditions: Dyslipidemia
NCT00688896

Completed

Efficacy and Safety Study of JTT-705 in Combination With Pravastatin 40 mg in Patients With Type II Hyperlipidemia

Conditions: Type II Hyperlipidemia
NCT00686010

Completed

Efficacy and Safety of JTT-705 300, 600 And 900mg in Comparison With Placebo in Patients With Type II Hyperlipidaemia

Conditions: Type II Hyperlipidaemia
NCT00655538

Completed

A Study Assessing the Effect of RO4607381 on Vascular Function in Patients With Coronary Heart Disease (CHD) or CHD-Risk Equivalent Patients

Conditions: Coronary Heart Disease
NCT00655473

Completed

A Study of the Effect of RO4607381 on Atherosclerotic Plaque in Patients With Coronary Heart Disease

Conditions: Coronary Heart Disease
NCT00400439

Completed

A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381

Conditions: Coronary Heart Disease
NCT00658515

Completed

A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome

Conditions: Coronary Heart Disease
NCT00697203

Completed

A Study to Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lipoprotein-Cholesterol (HDL-C)

Conditions: Dyslipidemia